Our Vision
is a world where no child is affected by eating disorders. Together, we can combat anorexia nervosa's grip until we find a cure. Your support ignites hope and ensures a healthier tomorrow for our children.
is a world where no child is affected by eating disorders. Together, we can combat anorexia nervosa's grip until we find a cure. Your support ignites hope and ensures a healthier tomorrow for our children.
is to identify and support novel high quality medical research that provides a pathway to the primary prevention of anorexia nervosa.
Download the 2025 Phase I Pre-proposal. Submission window closes on Friday, July 18th
download Phase 1 Pre-proposalThe specific purpose is to fund breakthrough research to establish the primary cause of eating disorders with an emphasis on Anorexia Nervosa to discover a path to the primary prevention of this mental illness.
Know MoreDr. Kyle, CEO and President of SKANRF is a serial entrepreneur, founder, CEO, and Chairman in the biotech field and has raised over $350M for three of his startups over the past 35 years. David also combines a distinguished scientific background with his commercial acumen, and has published over seventy-five scientific articles, edited two books, is the named inventor on over two hundred patents, and was inducted into the US Technology Hall of Fame in 2009, for his contributions to US Science and Industry.
Mr. Brown is a global, strategic CEO and Marketing Executive with 28 years of success across premier consumer, pharmaceutical and infant nutrition brands at Evolve BioSystems, Mead Johnson Nutrition and Procter & Gamble. He is experienced in raising startup financing, managing successful joint ventures and partnerships, interacting with Boards, and his expertise spans a variety of customers and channels in the developed and developing world. He has achieved outstanding results leveraging strategic vision, marketing/product and innovation, organizational development, team building and execution.
Mr. Kyle is the owner of COHA Ventures, whose investments include GT Ventures, Meridian, White Oak Creek Ranch, and Tate & Co. Distillery. Garry was also a co-founder and investor in Symplr, a Houston-based, comprehensive provider of credentialing and regulatory compliance software-as-a-service (SAAS) solutions to help healthcare organizations ensure governance, mitigate risk, and ensure compliance. Symplr was acquired by Clearlake Capital Group in 2018.
Dr. Setliff is a child, adolescent and adult psychiatrist living in Dallas, Texas. She is certified by the American Board of Psychiatry and Neurology and has specialized in the treatment of eating disorders for over 20 years. After developing and directing the eating disorders program at Children’s Health, she joined Eating Recovery Center and Pathlight Mood & Anxiety Center in January 2014 to develop and open ERC and Pathlight's Dallas treatment center. Dr. Setliff sits on several local and national Boards and speaks frequently at various eating disorder education, prevention, and treatment programs to increase awareness about eating disorders.
Father Mudd is the Executive Director for Advancement, Archbishop Carroll High School. He was born in Washington, D.C., and ordained a priest for the Archdiocese of Washington in 1969. He was appointed the Assistant Director of the Archdiocesan Office of Social Development in 1973. In this capacity Father Mudd developed educational materials and organized churches for involvement in urban and social justice issues. Fr. Mudd has built a firm base of individual, corporate, and foundation support for Archbishop Carroll High School that contributes over 2.3 million dollars a year to operations, scholarship, and tuition assistance. Fr. Mudd retired from full-time active ministry in the Archdiocese of Washington in 2015.
John Campbell earned his law degree from Yale Law School and his undergraduate degree in economics from Duke University. Over nearly four decades, he advised management teams, boards of directors, and financial intermediaries on complex financing, acquisitions, and transactions, representing companies in the life sciences and technology industries. Before retiring in 2022, he was a partner in the San Francisco office of Morrison & Foerster LLP and co-chaired their life sciences group. He played a key role in more than 40 initial public offerings and facilitated hundreds of venture capital financings, driving investments totaling billions.
Dr. Bulik is an internationally known and revered expert on eating disorders. She is a clinical psychologist and, is Distinguished Professor of Eating Disorders in the Department of Psychiatry, Professor of Nutrition in the Gillings School of Global Public Health and founding director of the University of North Carolina Center of Excellence for Eating Disorders. She is also professor of medical epidemiology and biostatistics at Karolinska Institute in Stockholm, Sweden, and has professorships in New Zealand, Norway, as well as Virginia Commonwealth University. Dr. Bulik has written 10 books, authored over 700 peer-reviewed publications, is the recipient of over $72M in investigator grants and has numerous awards including the Academy of Eating Disorders Lifetime Achievement Award in 2022.
Dr. Sylvester is a surgeon, scientist, academic & entrepreneur. A firm believer in the power of technology and innovation in the life sciences to bring about transformation in human health. He is a Professor of Surgery and Pediatrics, Associate Dean Maternal Child Health at Stanford University School of Medicine. He is also Executive in Residence at Mission BioCapital (San Carlos, CA), Chief Medical Advisor for Infinant Health (Davis, CA), Co-founder and Chief Medical Advisor of HBI Solutions (Palo Alto, CA) and Sr. Medical Advisor for Avexegen (San Diego, CA).
Dr. Mascolo has worked in the field of eating disorders for 15 years from bedside care of critically ill patients suffering from complications of starvation at the ACUTE Center for eating disorders at Denver Health, to Chief Medical Officer at Alsana. Dr. Mascolo earned her medical degree at the University of Texas and completed her residency in Internal Medicine at the University of Colorado in Denver. She is an Associate Professor of Medicine and maintains a visiting faculty appointment at the University of Colorado. Dr. Mascolo is board certified in Internal Medicine, has published multiple peer reviewed articles, travels nationally and internationally for speaking engagements, and has earned her certified eating disorder specialist certification.
Dr. Yuan is a general pediatrician and a senior pediatric gastroenterologist. He is the co-director of the Food Allergy Center at the Massachusetts General Hospital and an Associate Professor in Pediatrics at the Harvard Medical School. Dr. Yuan was appointed the inaugural incumbent of the Demarest Lloyd, Jr. Endowed Chair in Food Allergies in May 2023. Dr. Yuan is dedicated to advocating for his patients through collaboration with other physicians and scientists in pediatric allergy and immunology, child psychology/psychiatry, nutrition, and feeding and swallowing. Dr. Yuan’s research interests include food allergic diseases that affect the gastrointestinal tracts of children, particularly immunological factors in early infancy which affect a child’s eating and adverse reactions to food.
Dr. Rudolph is an independent consultant with expertise in Pediatric Nutrition. He previously served as the Vice President and Global Medical Director for Mead Johnson Nutrition. Prior roles included Vice-Chair and Professor of Pediatrics, and Director of the Section of Pediatric Gastroenterology and Nutrition at the Medical College of Wisconsin. He is an internationally recognized expert in pediatric nutrition, feeding disorders and gastrointestinal motility disorders in children. He was also editor-in-chief of RUDOLPH’s Pediatrics, one of the leading textbooks of pediatrics.
Dr. Walter Kaye attended Ohio State College of Medicine and completed a neurology residency at Los Angeles County-USC, a psychiatry residency at UCLA, and a research fellowship at the NIMH Clinical Center in Bethesda. Dr. Kaye was recruited to UC San Diego faculty from the University of Pittsburgh School of Medicine, where he was a professor of psychiatry and received a NIMH senior scientist award. At UCSD, Dr. Kaye was a Distinguished Professor of Psychiatry and Founder/Executive Director of the UCSD Eating Disorders Research and Treatment Center. He recently retired from UCSD and is an Emeritus Distinguished Professor. His research has focused on the relationship between brain and behavior using brain imaging and genetics, and on developing new treatments for anorexia and bulimia nervosa.
Richard Insel, MD is currently a Research Professor in the Department of Pediatrics at the University of Rochester School of Medicine & Dentistry. From 2016 to 2024 he held various positions at Johnson & Johnson, including Head of Pediatric Health & Wellness at Kenvue, Global Head of the Healthy Baby Initiative in the World Without Disease Accelerator at Janssen. From 2003 to 2016, he served as Executive Vice President of Research and Chief Scientific Officer at JDRF, overseeing the organization’s research strategy. Dr. Insel was affiliated with the University of Rochester Medical Center from 1977 to 2003 where he held several roles, including Professor of Pediatrics and Microbiology/Immunology, founding Director of the Center for Human Genetics and Molecular Pediatric Disease, Director of the Strong Children’s Research Center, and Chief of the Division of Pediatric Immunology, Allergy, and Rheumatology.
Thank you for subscribing to the SKANRF Newsletter!
We're currently crafting our first edition and will share it with you soon. Stay tuned for updates, insights, and more on advancing eating disorders research.
We're glad to have you with us!.